Last reviewed · How we verify
NCT03623997
Measuring Erythrocyte Iron Incorporation From Different Dosing Regimens in Anemic Women
trial testing Iron stable isotope labeled iron(II) sulfate in Iron Deficiency Anemia in 20 participants. Completed in 30 June 2018.
8 January 2018
Quick facts
| Lead sponsor | Swiss Federal Institute of Technology |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 10 October 2017 |
| Primary completion | 8 January 2018 |
| Estimated completion | 30 June 2018 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Iron stable isotope labeled iron(II) sulfate
Conditions studied
- Iron Deficiency Anemia — all drugs for Iron Deficiency Anemia →
Sponsor
Swiss Federal Institute of Technology
Who can join
Adults 18 to 45, female only, with Iron Deficiency Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Iron-deficient anaemic subjects are likely to benefit most from oral iron supplements, but supplementation schedules vary widely in clinical practice, absorption is low and compliance is poor due to mild gastrointestinal side effects. The investigators will compare iron absorption from labeled oral iron doses of 100mg and 200mg administered either on two consecutive days or on alternate days in young anemic women.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women.
Stoffel NU, Zeder C, Brittenham GM, Moretti D, et al · · 2020 · cited 128× · PMID 31413088 · DOI 10.3324/haematol.2019.220830
Verify or expand the search:
- PubMed search for NCT03623997
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Iron Deficiency Anemia
Currently open trials in the same condition.
- NCT07483645 — Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Ane · active not recruiting
- NCT06012760 — The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion · NA · recruiting
- NCT06742528 — Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients · NA · recruiting
- NCT05929729 — Iron Deficiency Anemia (IDA) and the Brain · Phase 4 · recruiting
- NCT05985070 — Evaluating the Effectiveness of Various Iron Salts in Oral Iron Therapy for Iron Deficiency and Anemia in Healthy Adults · NA · active not recruiting
Other Swiss Federal Institute of Technology trials
Trials by the same sponsor.
- NCT07182734 — Feasibility of Unsupervised Therapy After Neurological or Orthopaedical Injury in the Home Setting With a Hand Rehabilit · NA · not yet recruiting
- NCT06725784 — Feasibility and Cost of Robot-assisted Upper Limb Rehabilitation with Different Levels of Supervision · NA · recruiting
- NCT06851130 — Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women · NA · recruiting
- NCT06149975 — Feasibility of a Motor-cognitive Training Program in Patients With Traumatic Brain Injury · NA · completed
- NCT06116669 — Effects of Oral Iron Supplementation Before vs at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03623997 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Swiss Federal Institute of Technology
- Last refreshed: 22 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03623997.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing